Clinical Trials List
2025-03-01 - 2029-12-31
Others
Recruiting6
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- Sin-Syue Li Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- 張力常 Division of General Internal Medicine
- 傅蓓安 Division of Hematology & Oncology
- Ya-Ting Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Chih Liu Division of Hematology & Oncology
- 吳敬炫 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林耘曲 Division of General Internal Medicine
- 李思慧 Division of Family Medicine
- Tai-Chung Huang Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- Wen-Chien Chou Division of Others -
- 楊鎰聰 Division of General Internal Medicine
- - - Division of General Internal Medicine
- 袁章祖 Division of Others
- Chien-Chin Lin Division of Others -
- 柯紀綸 Division of Nuclear Medicine
- YAO CHI-YUAN Division of Others -
- Chieh-Lung Cheng Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳宜穎 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 劉韋農 Division of Hematology & Oncology
- 李卓豪 Division of Hematology & Oncology
- 陳昱光 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡淳光 Division of Hematology & Oncology
- 陳玟均 Division of Hematology & Oncology
- Sheng-Hsuan Chien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
486 participants